Culver City, CA, United States of America

Lise Geissert

This inventor holds 4 USPTO granted patents and 3 published patent applications. Top assignees: Immunitybio, Inc., Nantbio, Inc.. Active years: 2024-2026.

USPTO Granted Patents = 4 (Patent Applications = 3)

% Patents Active = 100.0

Average Co-Inventor Count = 7.6

ph-index = 1

Company Filing History:

Years Active: 2024-2026

Loading Chart...

4 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12545928 - Machine Methods To Determine Neoepitope Payload Toxicity (2026-02-10),

2. 12448638 - Enzyme based system for production of messenger RNA with increased transfection efficiency (2025-10-21),

3. 12290558 - SARS-CoV-2 vaccines comprising human adenovirus vectors encoding spike and nucleocapsid-ETSD immunogens (2025-05-06),

4. 11857620 - Method of inducing immunity against SARS-CoV-2 using spike (s) and nucleocapsid (N)-ETSD immunogens delivered by a replication-defective adenovirus (2024-01-02),

I specialize in innovations, inventions, inventors, patent attorneys, assignees, and patents.

Profile summary based on public USPTO records.

Please report any incorrect information to [email protected]

3 patents pending:

Please report any incorrect information to [email protected]

2 patents pending (CIPO):

Please report any incorrect information to [email protected]

3 patents pending (EPO):

Please report any incorrect information to [email protected]